RE:RE:RE:RE:A nibble MrMugsy wrote: Goodman lent Appili Therapeutics a couple million dollars at 8.5% through his holding company.
He also received rights to future drugs in Canada, LATAM and Israel.
I checked on this because it worried me ... thought that GUD was potentially competing against Goodman. Not so as per Samira ... she didn't want the deal.
She's looking for better guarantees.
She's probably also looking for faster-to-market products right now. IMO.
Goodman tabled an offer and Appili accepted the terms.
------------------------
gudisgood wrote: MrMugsy wrote: I checked in with Samira on this deal back in March.
She chose to take a pass on this one - sounds like she didn't care for the risk profile.
Then, Goodman offered to lend.
------------------------------------------
If the assets ever come to market, I'm guessing Goodman would liikely offer rights sale to us.
Hey MrMugsy, can you explain this a little bit more? What are we talking about here? :D
Ahh okay, thanks. The opening post of this thread was about Goodman buying a tiny amount of Knight stock -- therefore I was confused about what you meant. But it's nice to know about the Appili deal. And quite interesting to know that it's something Goodman found acceptable but Samira didn't. :)